Cargando…

US health care utilization and costs in adult patients with atopic dermatitis by disease severity

BACKGROUND: Although previous studies have reported the economic burden of atopic dermatitis (AD) in adults, updates are needed using more current data and measure of disease severity. OBJECTIVE: To describe the health care resource utilization (HCRU) and associated costs in US adults diagnosed with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xin, Boytsov, Natalie N, Gorritz, Magdaliz, Malatestinic, William N, Goldblum, Orin M, Wade, Rolin L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2022
Materias:	Research Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373046/ https://www.ncbi.nlm.nih.gov/pubmed/34949118 http://dx.doi.org/10.18553/jmcp.2022.28.1.69

Ejemplares similares

The direct and indirect costs of adult atopic dermatitis
por: Manjelievskaia, Janna, et al.
Publicado: (2021)

A Qualitative Analysis of Provider Notes of Atopic Dermatitis-Related Visits Using Natural Language Processing Methods
por: Pierce, Evangeline J., et al.
Publicado: (2021)

Previously unrecognized risk factors for severe hypoglycaemia requiring emergency medical care in insulin‐treated type 2 diabetes: Results from a real‐world nested case‐control study
por: Settles, Julie, et al.
Publicado: (2022)

Prescription Market Share and Treatment Patterns in Atopic Dermatitis: A Retrospective Observational Study Using US Insurance Claims
por: Fenske, Christian, et al.
Publicado: (2022)

Influence of Weight Loss on Severity of Atopic Dermatitis in a 20-Year-Old Female with Atopic Dermatitis
por: Son, Jee Hee, et al.
Publicado: (2018)

The ability of biomarkers to assess the severity of atopic dermatitis
por: Nakahara, Takeshi, et al.
Publicado: (2023)

Patient Characteristics, Health Care Resource Utilization, and Costs Associated with Treatment-Regimen Failure with Biologics in the Treatment of Psoriasis
por: A. Foster, Shonda, et al.
Publicado: (2016)

Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization
por: Armstrong, April W., et al.
Publicado: (2018)

The Incidence, Prevalence, and Associated Costs of Anemia, Malignancy, Venous Thromboembolism, Major Adverse Cardiovascular Events, and Infections in Rheumatoid Arthritis Patients by Treatment History in the United States
por: Dore, Robin K., et al.
Publicado: (2021)

Atopic dermatitis
por: Watson, Wade, et al.
Publicado: (2011)

Atopic dermatitis
por: Kapur, Sandeep, et al.
Publicado: (2018)

Quantifying Costs Associated with Atopic Dermatitis
por: Ellis, Charles N., et al.
Publicado: (2003)

The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trials
por: Yosipovitch, Gil, et al.
Publicado: (2022)

Real-Life Effectiveness and Tolerance of Upadacitinib for Severe Atopic Dermatitis in Adolescents and Adults
por: De Greef, Axel, et al.
Publicado: (2023)

Hair Mineral Analysis in Children with Atopic Dermatitis
por: Kim, Jeong Eun, et al.
Publicado: (2017)

Autologous Immunoglobulin Therapy in Patients With Severe Recalcitrant Atopic Dermatitis: A Preliminary Report
por: Nahm, Dong-Ho, et al.
Publicado: (2014)

Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
por: de Bruin-Weller, Marjolein S., et al.
Publicado: (2022)

Cost of Care of Atopic Dermatitis in India
por: Handa, Sanjeev, et al.
Publicado: (2015)

Basement Membrane Status Is Intact in Urticarial Dermatitis vs. Adult-Onset Atopic Dermatitis
por: Kim, Tae In, et al.
Publicado: (2018)

Immunoglobulin free light chains in adult atopic dermatitis patients do not correlate with disease severity
por: Thijs, J. L., et al.
Publicado: (2016)

Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis
por: Paller, Amy S., et al.
Publicado: (2022)

Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis: A Secondary Analysis
por: Merola, Joseph F., et al.
Publicado: (2023)

MRGPRX2, atopic dermatitis, and red man syndrome
por: Azimi, Ehsan, et al.
Publicado: (2017)

Impact of COVID-19 Pandemic on Patients with Atopic Dermatitis
por: Pourani, M.R., et al.
Publicado: (2022)

Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)

Autologous Immunoglobulin Therapy in Patients With Severe Recalcitrant Atopic Dermatitis: Long-Term Changes of Clinical Severity and Laboratory Parameters
por: Nahm, Dong-Ho, et al.
Publicado: (2016)

Hospital Utilization and Medication Prescriptions among Patients with Atopic Dermatitis in South Korea: A Real-World Data Analysis
por: Lee, Ji Hyun, et al.
Publicado: (2023)

Current Status of Patient Education in the Management of Atopic Dermatitis in Korea
por: Lee, Min Kyung, et al.
Publicado: (2019)

Process utilities for topical treatment in atopic dermatitis
por: Retzler, Jenny, et al.
Publicado: (2019)

Management of Atopic Dermatitis: Clinical Utility of Ruxolitinib
por: Owji, Shayan, et al.
Publicado: (2022)

Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis
por: Armstrong, April W., et al.
Publicado: (2019)

No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab
por: Blauvelt, Andrew, et al.
Publicado: (2022)

Association of Atopic Dermatitis with Dyslipidemia in Adolescents: A Cross-Sectional Study
por: Leigh, Ja-Ho, et al.
Publicado: (2021)

Practical Recommendations for the Topical Treatment of Atopic Dermatitis in South and East Asia
por: Luk, David, et al.
Publicado: (2020)

Time Trends in the Prevalence of Atopic Dermatitis in Korean Children According to Age
por: Lee, Ji Young, et al.
Publicado: (2021)

New Onset of Alcohol Flushing in an Atopic Dermatitis Patient Treated with Dupilumab
por: Choi, Hoon, et al.
Publicado: (2023)

Probabilistic Linkage of Randomized Controlled Trial Data to Administrative Claims: A Case Study of Patients from Baricitinib Clinical Trials
por: McGuiness, Catherine B., et al.
Publicado: (2021)

Cost Effectiveness of Emollients in the Prevention of Relapses in Atopic Dermatitis
por: Cabout, Elise, et al.
Publicado: (2020)

The Effectiveness of Tailored Education on the Usage of Moisturizers in Atopic Dermatitis: A Pilot Study
por: Park, Gyeong Yul, et al.
Publicado: (2017)

Treatment complexity and caregiver burden are linked in owners of dogs with allergic/atopic dermatitis
por: Spitznagel, Mary Beth, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s45mutje7ucblt33uho9od9kas